---
$id: https://graph.org.ai/products/commodity/51152070
$type: Product
source: UNSPSC
code: "51152070"
title: "Rocuronium bromide"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rocuronium bromide

**UNSPSC Code**: 51152070
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant with the molecular formula C32H53N2O4.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I65MW4OFHZ, chemically known as 1-allyl-1-(3alpha,17beta-dihydroxy-2beta-morpholino-5alpha-androstan-16beta-yl)pyrrolidinium bromide, 17-acetate but more generally known as rocuronium bromide, which bears US NIH Compound Identifier 60695. European Medicines Agency schedules Rocuronium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10353MIG. The term ROCURONIUM BROMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules rocuronium bromide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule rocuronium bromide under HS 29349990 and SITC 51579. As of Q4 2014, ROCURONIUM BROMIDE remains US FDA's Preferred Term for this commodity. Rocuronium bromide bears US NLM identifiers UMLS ID C0591463 and NCI Concept Code C47709. SMILES: CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[BR-].

